Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GENENE P RADDEN

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1710917422
CMS profile
867153
Location
CHAMPAIGN, IL

General Payments · PY2018–2024

$4,322.84

  • Reported across 238 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$627.73

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $598.13 33
Education $29.60 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $212.25 10
NOVARTIS PHARMACEUTICALS CORPORATION $130.69 11
ABBVIE INC. $65.55 3
Lilly USA, LLC $49.59 3
GENZYME CORPORATION $43.75 2
UCB, Inc. $32.33 1
E.R. Squibb & Sons, L.L.C. $29.60 2
Janssen Biotech, Inc. $25.11 1
Acerta Pharma LLC $23.82 1
Alexion Pharmaceuticals, Inc. $15.04 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $718.44 43
PY2019 $900.63 38
PY2020 $132.91 7
PY2021 $510.68 31
PY2022 $764.94 46
PY2023 $667.51 38
PY2024 $627.73 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $24.37 02/07/2024 Food and Beverage Undisputed 01/23/2026 1105346309 CMS
ABBVIE INC. $22.67 07/17/2024 Food and Beverage Undisputed 01/23/2026 1105346313 CMS
ABBVIE INC. $18.51 12/17/2024 Food and Beverage Undisputed 01/23/2026 1105346317 CMS
Alexion Pharmaceuticals, Inc. $15.04 08/07/2024 Food and Beverage Undisputed 01/23/2026 1093964147 CMS
Amgen Inc. $12.61 02/13/2024 Food and Beverage Undisputed 01/23/2026 1111681640 CMS
Amgen Inc. $30.97 02/27/2024 Food and Beverage Undisputed 01/23/2026 1111681642 CMS
Amgen Inc. $27.41 04/16/2024 Food and Beverage Undisputed 01/23/2026 1111681644 CMS
Amgen Inc. $17.31 05/07/2024 Food and Beverage Undisputed 01/23/2026 1111681636 CMS
Amgen Inc. $21.73 07/11/2024 Food and Beverage Undisputed 01/23/2026 1111681638 CMS
Amgen Inc. $22.85 07/24/2024 Food and Beverage Undisputed 01/23/2026 1117359460 CMS
Amgen Inc. $30.30 08/15/2024 Food and Beverage Undisputed 01/23/2026 1117359454 CMS
Amgen Inc. $5.03 08/20/2024 Food and Beverage Undisputed 01/23/2026 1111681634 CMS
Amgen Inc. $11.42 11/20/2024 Food and Beverage Undisputed 01/23/2026 1117359456 CMS
Amgen Inc. $32.62 12/18/2024 Food and Beverage Undisputed 01/23/2026 1117359458 CMS
AstraZeneca Pharmaceuticals LP $23.82 05/01/2024 Food and Beverage Undisputed 01/23/2026 1104270241 CMS
E.R. Squibb & Sons, L.L.C. $14.80 01/25/2024 Education Undisputed 01/23/2026 1101358490 CMS
E.R. Squibb & Sons, L.L.C. $14.80 02/26/2024 Education Undisputed 01/23/2026 1101358494 CMS
GENZYME CORPORATION $20.34 08/06/2024 Food and Beverage Undisputed 01/23/2026 1139963743 CMS
GENZYME CORPORATION $23.41 10/15/2024 Food and Beverage Undisputed 01/23/2026 1139963753 CMS
Janssen Biotech, Inc. $25.11 04/11/2024 Food and Beverage Undisputed 01/23/2026 1078574720 CMS
Lilly USA, LLC $21.62 08/06/2024 Food and Beverage Undisputed 01/23/2026 1134985802 CMS
Lilly USA, LLC $14.44 08/23/2024 Food and Beverage Undisputed 01/23/2026 1134997800 CMS
Lilly USA, LLC $13.53 11/21/2024 Food and Beverage Undisputed 01/23/2026 1134997798 CMS
Novartis Pharmaceuticals Corporation $8.07 03/26/2024 Food and Beverage Undisputed 01/23/2026 1087211413 CMS
Novartis Pharmaceuticals Corporation $16.43 05/10/2024 Food and Beverage Undisputed 01/23/2026 1087211415 CMS
Novartis Pharmaceuticals Corporation $3.95 05/21/2024 Food and Beverage Undisputed 01/23/2026 1087211417 CMS
Novartis Pharmaceuticals Corporation $26.26 06/04/2024 Food and Beverage Undisputed 01/23/2026 1087211419 CMS
Novartis Pharmaceuticals Corporation $4.83 06/28/2024 Food and Beverage Undisputed 01/23/2026 1087211423 CMS
Novartis Pharmaceuticals Corporation $22.87 07/23/2024 Food and Beverage Undisputed 01/23/2026 1087211425 CMS
Novartis Pharmaceuticals Corporation $7.86 08/07/2024 Food and Beverage Undisputed 01/23/2026 1087211427 CMS
Novartis Pharmaceuticals Corporation $6.41 08/16/2024 Food and Beverage Undisputed 01/23/2026 1087211429 CMS
Novartis Pharmaceuticals Corporation $5.13 08/26/2024 Food and Beverage Undisputed 01/23/2026 1087211431 CMS
Novartis Pharmaceuticals Corporation $6.18 10/02/2024 Food and Beverage Undisputed 01/23/2026 1087211435 CMS
Novartis Pharmaceuticals Corporation $22.70 11/26/2024 Food and Beverage Undisputed 01/23/2026 1087211439 CMS
UCB, Inc. $32.33 02/15/2024 Food and Beverage Undisputed 01/23/2026 1143189422 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.